Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.73 is 47% above its 5-year average of -1.37, near the high end of its 5-year range (-1.86–-0.73).
50.51% above its 12-month average of -1.48.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 0.08.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 19 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.73
EARNINGS PER SHARE (EPS) AVG TTM
-1.48
EARNINGS PER SHARE (EPS) AVG 3Y
-1.47
EARNINGS PER SHARE (EPS) AVG 5Y
-1.37
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+50.51%
CURRENT VS 3Y AVG
+50.17%
CURRENT VS 5Y AVG
+46.64%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Werewolf Therapeutics, Inc.
Market Cap
$45.07M
Earnings Per Share (EPS)
-0.73
TTM Avg
-1.48
3Y Avg
-1.47
5Y Avg
-1.37
Market Cap
$45.37M
Earnings Per Share (EPS)
0.69
TTM Avg
-0.78
3Y Avg
-1.53
5Y Avg
-2.71
Market Cap
$45.60M
Earnings Per Share (EPS)
-1.68
TTM Avg
0.78
3Y Avg
0.08
5Y Avg
-0.02
Market Cap
$46.96M
Earnings Per Share (EPS)
-9.11
TTM Avg
-2.23
3Y Avg
-1.64
5Y Avg
-3.32
Market Cap
$42.46M
Earnings Per Share (EPS)
-0.87
TTM Avg
-1.21
3Y Avg
-1.66
5Y Avg
-1.49
Market Cap
$42.19M
Earnings Per Share (EPS)
-1.98
TTM Avg
-2.34
3Y Avg
-2.17
5Y Avg
-1.92
Market Cap
$48.03M
Earnings Per Share (EPS)
-2.83
TTM Avg
-3.12
3Y Avg
-4.06
5Y Avg
-22.86
Market Cap
$39.91M
Earnings Per Share (EPS)
-2.49
TTM Avg
-2.22
3Y Avg
-1.86
5Y Avg
-2.21
Market Cap
$49.00M
Earnings Per Share (EPS)
-3.55
TTM Avg
-4.16
3Y Avg
-5.92
5Y Avg
-5.28
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Werewolf Therapeutics, Inc. (HOWL) | $45.07M | -0.73 | -1.48 | -1.47 | -1.37 |
| DarioHealth Corp. (DRIO)vs › | $45.37M | 0.69 | -0.78 | -1.53 | -2.71 |
| BioStem Technologies, Inc. (BSEM)vs › | $45.60M | -1.68 | 0.78 | 0.08 | -0.02 |
| Lite Strategy, Inc. (LITS)vs › | $46.96M | -9.11 | -2.23 | -1.64 | -3.32 |
| Filana Therapeutics, Inc. (FLNA)vs › | $42.46M | -0.87 | -1.21 | -1.66 | -1.49 |
| CVRx, Inc. (CVRX)vs › | $42.19M | -1.98 | -2.34 | -2.17 | -1.92 |
| Celularity Inc. (CELU)vs › | $48.03M | -2.83 | -3.12 | -4.06 | -22.86 |
| Metagenomi, Inc. Common Stock (MGX)vs › | $39.91M | -2.49 | -2.22 | -1.86 | -2.21 |
| Clene Inc. (CLNN)vs › | $49.00M | -3.55 | -4.16 | -5.92 | -5.28 |
| Incannex Healthcare Limited (IXHL)vs › | $38.82M | N/A | -21.23 | -13.85 | -9.58 |
Trailing EPS (TTM)
$-0.73
Forward EPS (Est.)
$-0.89
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.32 |
| 2024-12-31 | -1.63 |
| 2023-12-31 | -1.05 |
| 2022-12-31 | -1.86 |
| 2020-12-31 | -0.98 |
| 2019-12-31 | -0.38 |
